|
1
|
Ali MU, Rahman MSU, Cao J and Yuan PX:
Genetic characterization and disease mechanism of retinitis
pigmentosa; current scenario. 3 Biotech. 7(251)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pearlman JT: Mathematical models of
retinitis pigmentosa: A study of the rate of progress in the
different genetic forms. Trans Am Ophthalmol Soc. 77:643–656.
1979.PubMed/NCBI
|
|
3
|
Ferrari S, Di Iorio E, Barbaro V, Ponzin
D, Sorrentino FS and Parmeggiani F: Retinitis pigmentosa: Genes and
disease mechanisms. Curr Genomics. 12:238–249. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen X, Liu X, Sheng X, Gao X, Zhang X, Li
Z, Li H, Liu Y, Rong W, Zhao K and Zhao C: Targeted next-generation
sequencing reveals novel EYS mutations in Chinese families with
autosomal recessive retinitis pigmentosa. Sci Rep.
5(8927)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Xiao X, Cao Y, Zhang Z, Xu Y, Zheng Y,
Chen LJ, Pang CP and Chen H: Novel mutations in PRPF31 causing
retinitis pigmentosa identified using whole-exome sequencing.
Invest Ophthalmol Vis Sci. 58:6342–6350. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Grondahl J: Estimation of prognosis and
prevalence of retinitis pigmentosa and Usher syndrome in Norway.
Clin Genet. 31:255–264. 1987.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Paloma E, Martínez-Mir A, García-Sandoval
B, Ayuso C, Vilageliu L, Gonzàlez-Duarte R and Balcells S: Novel
homozygous mutation in the alpha subunit of the rod cGMP gated
channel (CNGA1) in two Spanish sibs affected with autosomal
recessive retinitis pigmentosa. J Med Genet. 39(E66)2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bunker CH, Berson EL, Bromley WC, Hayes RP
and Roderick TH: Prevalence of retinitis pigmentosa in maine. Am J
Ophthalmol. 97:357–365. 1984.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xu J, Morris LM, Michalakis S, Biel M,
Fliesler SJ, Sherry DM and Ding XQ: CNGA3 deficiency affects cone
synaptic terminal structure and function and leads to secondary rod
dysfunction and degeneration. Invest Ophthalmol Vis Sci.
53:1117–1129. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yang RB, Robinson SW, Xiong WH, Yau KW,
Birch DG and Garbers DL: Disruption of a retinal guanylyl cyclase
gene leads to cone-specific dystrophy and paradoxical rod behavior.
J Neurosci. 19:5889–5897. 1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang Z, Peachey NS, Moshfeghi DM,
Thirumalaichary S, Chorich L, Shugart YY, Fan K and Zhang K:
Mutations in the RPGR gene cause X-linked cone dystrophy. Hum Mol
Genet. 11:605–611. 2002.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu DY, Cringle S, Valter K, Walsh N, Lee D
and Stone J: Photoreceptor death, trophic factor expression,
retinal oxygen status, and photoreceptor function in the P23H rat.
Invest Ophthalmol Vis Sci. 45:2013–2019. 2004.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Michaelides M, Hardcastle AJ, Hunt DM and
Moore AT: Progressive cone and cone-rod dystrophies: Phenotypes and
underlying molecular genetic basis. Surv Ophthalmol. 51:232–258.
2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Narayan DS, Wood JP, Chidlow G and Casson
RJ: A review of the mechanisms of cone degeneration in retinitis
pigmentosa. Acta Ophthalmol. 94:748–754. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
den Hollander AI, Roepman R, Koenekoop RK
and Cremers FP: Leber congenital amaurosis: genes, proteins and
disease mechanisms. Prog Retin Eye Res. 27:391–419. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang L, Xiao X, Li S, Jia X, Wang P, Guo
X and Zhang Q: CRX variants in cone-rod dystrophy and mutation
overview. Biochem Biophys Res Commun. 426:498–503. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nichols LL II, Alur RP, Boobalan E,
Sergeev YV, Caruso RC, Stone EM, Swaroop A, Johnson MA and Brooks
BP: Two novel CRX mutant proteins causing autosomal dominant Leber
congenital amaurosis interact differently with NRL. Hum Mutat.
31:E1472–E1483. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Walia S, Fishman GA, Jacobson SG, Aleman
TS, Koenekoop RK, Traboulsi EI, Weleber RG, Pennesi ME, Heon E,
Drack A, et al: Visual acuity in patients with Leber's congenital
amaurosis and early childhood-onset retinitis pigmentosa.
Ophthalmology. 117:1190–1198. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chung JK, Shin JH, Jeon BR, Ki CS and Park
TK: Optical coherence tomographic findings of crystal deposits in
the lens and cornea in Bietti crystalline corneoretinopathy
associated with mutation in the CYP4V2 gene. Jpn J Ophthalmol.
57:447–450. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Association WM: World Medical Association
Declaration of Helsinki: Ethical principles for medical research
involving human subjects. JAMA. 310:2191–2194. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sorrentino FS, Gallenga CE, Bonifazzi C
and Perri P: A challenge to the striking genotypic heterogeneity of
retinitis pigmentosa: A better understanding of the pathophysiology
using the newest genetic strategies. Eye (Lond). 30:1542–1548.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang Y, Guo L, Cai SP, Dai M, Yang Q, Yu
W, Yan N, Zhou X, Fu J, Guo X, et al: Exome sequencing identifies
compound heterozygous mutations in CYP4V2 in a pedigree with
retinitis pigmentosa. PLoS One. 7(e33673)2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xiao X, Mai G, Li S, Guo X and Zhang Q:
Identification of CYP4V2 mutation in 21 families and overview of
mutation spectrum in Bietti crystalline corneoretinal dystrophy.
Biochem Biophys Res Commun. 409:181–186. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yin H, Jin C, Fang X, Miao Q, Zhao Y, Chen
Z, Su Z, Ye P, Wang Y and Yin J: Molecular analysis and phenotypic
study in 14 Chinese families with Bietti crystalline dystrophy.
PLoS One. 9(e94960)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin J, Nishiguchi KM, Nakamura M, Dryja
TP, Berson EL and Miyake Y: Recessive mutations in the CYP4V2 gene
in East Asian and Middle Eastern patients with Bietti crystalline
corneoretinal dystrophy. J Med Genet. 42(e38)2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li A, Jiao X, Munier FL, Schorderet DF,
Yao W, Iwata F, Hayakawa M, Kanai A, Shy Chen M, Alan Lewis R, et
al: Bietti crystalline corneoretinal dystrophy is caused by
mutations in the novel gene CYP4V2. Am J Hum Genet. 74:817–826.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Branham K, Othman M, Brumm M, Karoukis AJ,
Atmaca-Sonmez P, Yashar BM, Schwartz SB, Stover NB, Trzupek K,
Wheaton D, et al: Mutations in RPGR and RP2 account for 15% of
males with simplex retinal degenerative disease. Invest Ophthalmol
Vis Sci. 53:8232–8237. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kumaran N, Moore AT, Weleber RG and
Michaelides M: Leber congenital amaurosis/early-onset severe
retinal dystrophy: Clinical features, molecular genetics and
therapeutic interventions. Br J Ophthalmol. 101:1147–1154.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Thompson DA, Gyurus P, Fleischer LL,
Bingham EL, McHenry CL, Apfelstedt-Sylla E, Zrenner E, Lorenz B,
Richards JE, Jacobson SG, et al: Genetics and phenotypes of RPE65
mutations in inherited retinal degeneration. Invest Ophthalmol Vis
Sci. 41:4293–4299. 2000.PubMed/NCBI
|
|
31
|
Hull S, Holder GE, Robson AG, Mukherjee R,
Michaelides M, Webster AR and Moore AT: Preserved visual function
in retinal dystrophy due to hypomorphic RPE65 mutations. Br J
Ophthalmol. 100:1499–1505. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Badano JL, Leitch CC, Ansley SJ,
May-Simera H, Lawson S, Lewis RA, Beales PL, Dietz HC, Fisher S and
Katsanis N: Dissection of epistasis in oligogenic Bardet-Biedl
syndrome. Nature. 439:326–330. 2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jiao X, Li A, Jin ZB, Wang X, Iannaccone
A, Traboulsi EI, Gorin MB, Simonelli F and Hejtmancik JF:
Identification and population history of CYP4V2 mutations in
patients with Bietti crystalline corneoretinal dystrophy. Eur J Hum
Genet. 25:461–471. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Meng XH, Guo H, Xu HW, Li QY, Jin X, Bai
Y, Li SY and Yin ZQ: Identification of novel CYP4V2 gene mutations
in 92 Chinese families with Bietti's crystalline corneoretinal
dystrophy. Mol Vis. 20:1806–1814. 2014.PubMed/NCBI
|
|
35
|
Lockhart CM, Nakano M, Rettie AE and Kelly
EJ: Generation and characterization of a murine model of Bietti
crystalline dystrophy. Invest Ophthalmol Vis Sci. 55:5572–5581.
2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kelly EJ, Nakano M, Rohatgi P,
Yarov-Yarovoy V and Rettie AE: Finding homes for orphan cytochrome
P450s: CYP4V2 and CYP4F22 in disease states. Mol Interv.
11:124–132. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Giusto NM, Pasquare SJ, Salvador GA,
Castagnet PI, Roque ME and Ilincheta de Boschero MG: Lipid
metabolism in vertebrate retinal rod outer segments. Prog Lipid
Res. 39:315–391. 2000.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shimizu T: Binding of cysteine thiolate to
the Fe(III) heme complex is critical for the function of heme
sensor proteins. J Inorg Biochem. 108:171–177. 2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shan M, Dong B, Zhao X, Wang J, Li G, Yang
Y and Li Y: Novel mutations in the CYP4V2 gene associated with
Bietti crystalline corneoretinal dystrophy. Mol Vis. 11:738–743.
2005.PubMed/NCBI
|
|
40
|
Jin ZB, Ito S, Saito Y, Inoue Y, Yanagi Y
and Nao IN: Clinical and molecular findings in three Japanese
patients with crystalline retinopathy. Jpn J Ophthalmol.
50:426–431. 2006.PubMed/NCBI View Article : Google Scholar
|
